NASDAQ:DRIO DarioHealth (DRIO) Stock Price, News & Analysis $0.96 -0.04 (-4.00%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About DarioHealth Stock (NASDAQ:DRIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DarioHealth alerts:Sign Up Key Stats Today's Range$0.95▼$1.0050-Day Range$0.78▼$1.1352-Week Range$0.68▼$2.60Volume27,236 shsAverage Volume113,736 shsMarket Capitalization$28.73 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company OverviewDarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Read More… Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover DarioHealth Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks58th Percentile Overall ScoreDRIO MarketRank™: DarioHealth scored higher than 58% of companies evaluated by MarketBeat, and ranked 521st out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingDarioHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageDarioHealth has received no research coverage in the past 90 days.Read more about DarioHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DarioHealth are expected to grow in the coming year, from ($1.21) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DarioHealth is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DarioHealth is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDarioHealth has a P/B Ratio of 0.45. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DarioHealth's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.88% of the outstanding shares of DarioHealth have been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 18.7, which indicates bearish sentiment.Change versus previous monthShort interest in DarioHealth has recently decreased by 0.56%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDarioHealth does not currently pay a dividend.Dividend GrowthDarioHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.88% of the outstanding shares of DarioHealth have been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 18.7, which indicates bearish sentiment.Change versus previous monthShort interest in DarioHealth has recently decreased by 0.56%, indicating that investor sentiment is improving. News and Social Media2.7 / 5News Sentiment0.94 News SentimentDarioHealth has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for DarioHealth this week, compared to 1 article on an average week. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, DarioHealth insiders have bought more of their company's stock than they have sold. Specifically, they have bought $16,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders15.70% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.39% of the stock of DarioHealth is held by institutions.Read more about DarioHealth's insider trading history. Receive DRIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address DRIO Stock News HeadlinesDarioHealth signs new regional health planOctober 31 at 3:56 PM | markets.businessinsider.comDario Signs New Regional Health Plan, Expanding Reach in Medicaid PopulationOctober 30 at 8:30 AM | prnewswire.com[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.October 31, 2024 | Crypto Swap Profits (Ad)DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7thOctober 23, 2024 | prnewswire.comDario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition PlatformOctober 17, 2024 | prnewswire.comTwill by Dario to Offer a Benefit for AARP MembersOctober 15, 2024 | prnewswire.comDarioHealth Corp (DRIO) Q2 2024 Earnings Call Highlights: Strong B2B2C Growth and Strategic ShiftsOctober 9, 2024 | finance.yahoo.comZacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin GalacticOctober 3, 2024 | finance.yahoo.comSee More Headlines DRIO Stock Analysis - Frequently Asked Questions How have DRIO shares performed this year? DarioHealth's stock was trading at $1.72 at the start of the year. Since then, DRIO shares have decreased by 44.2% and is now trading at $0.9601. View the best growth stocks for 2024 here. How were DarioHealth's earnings last quarter? DarioHealth Corp. (NASDAQ:DRIO) announced its quarterly earnings results on Thursday, August, 8th. The company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.51) by $0.43. The firm had revenue of $6.26 million for the quarter, compared to analysts' expectations of $7.57 million. DarioHealth had a negative net margin of 265.33% and a negative trailing twelve-month return on equity of 74.64%. Does DarioHealth have any subsidiaries? DarioHealth subsidiaries include PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc.. Who are DarioHealth's major shareholders? Top institutional shareholders of DarioHealth include DLK Investment Management LLC (0.34%) and Clarity Capital Partners LLC (0.09%). Insiders that own company stock include Erez Raphael, Steven Charles Nelson and Dror Bacher. View institutional ownership trends. How do I buy shares of DarioHealth? Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of DarioHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include Palantir Technologies (PLTR), NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA). Company Calendar Last Earnings8/08/2024Today10/31/2024Next Earnings (Confirmed)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:DRIO CUSIPN/A CIK1533998 Webwww.mydario.com Phone(833) 914-3796Fax972-4770-4059Employees200Year Founded2011Price Target and Rating Average Stock Price Target$4.00 High Stock Price Target$4.00 Low Stock Price Target$4.00 Potential Upside/Downside+316.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-59,430,000.00 Net Margins-265.33% Pretax Margin-275.41% Return on Equity-74.64% Return on Assets-43.99% Debt Debt-to-Equity Ratio0.34 Current Ratio2.26 Quick Ratio1.96 Sales & Book Value Annual Sales$19.15 million Price / Sales1.50 Cash FlowN/A Price / Cash FlowN/A Book Value$2.14 per share Price / Book0.45Miscellaneous Outstanding Shares29,923,000Free Float25,314,000Market Cap$28.73 million OptionableOptionable Beta1.48 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:DRIO) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.